Brief: Taro Q3 sales USD 157.145 million
Jan 25 (Reuters) - Taro Q3 gross profit USD 79.881 million. * Q3 operating income USD 15.883 million * Q3 sales USD 157.145 million * Q3 net income USD 20.208 million
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma